background image

Paid Clinical Trials New Haven

Discover 1,108 paid clinical trials in New Haven, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & ResponsiveNew

Investigation of Lymph Node Biology in Kidney Cancer

for
Renal Cell Carcinoma (RCC)
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07038733

Recruiting
Active & Responsive

Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life

for
Wellness, Quality of Life, Anxiety, Depression
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18 - 65

Code: NCT05810259

Recruiting
Active & Responsive

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

for
Glioblastoma, IDH1 Gene Mutation, IDH2 Gene Mutation,
Location: New Haven CT, Hackensack NJ, Boston MA, Philadelphia PA,
Sponsor: University of California, San Francisco

Sex: All

Age: 13 - 39

Code: NCT03749187

Phase1, Recruiting
Active & Responsive

Neurophysiological Benefits of Live Music for Early Alzheimer's Patients and Their Caregivers

for
Alzheimer Disease, Dementia, Mild Cognitive Impairment,
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 50 - 70+

Code: NCT06940687

Recruiting
Active & Responsive

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

for
Colonic Neoplasms, Neoplasms, Colon
Location: New Haven CT, The Bronx NY, New York NY, Lebanon NH,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05855200

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

for
PIK3CA Mutation, Solid Tumor, Adult,
Location: New Haven CT, New York NY, New Brunswick NJ, Boston MA,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05216432

Phase1, Recruiting
Active & Responsive

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

for
Metastatic Breast Cancer
Location: New Haven CT, North Haven CT, Derby CT, Guilford CT,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 65+

Code: NCT06377852

Phase3, Recruiting
Active & Responsive

A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors

for
Solid Tumor
Location: New Haven CT, The Bronx NY, Boston MA, Philadelphia PA,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06619587

Phase1, Recruiting
Active & Responsive

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: New Haven CT, New York NY, Boston MA, Philadelphia PA,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT05787587

Phase1, Recruiting
Active & Responsive

ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions

for
Myelodysplastic Syndromes
Location: New Haven CT, Hartford CT, Hackensack NJ, Bethesda MD,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05949684

Phase3, Recruiting